Title of Invention

A PROCESS FOR PREPARING AN AYURVEDIC MEDICAMENT EFFECTIVE AGAINST LEUKAEMIA AND CARCINOMA OF LUNG AND INTESTINE

Abstract Conventional treatment for different forms of carcinoma has been quite expensive and often shows undesirable side effects. The present invention attempts to mitigate the sufferings of patients suffering from carcinoma and provides a process for preparing an ayurvedic medicament effective against Leukaemia and certain forms of carcinoma which comprises- (a) mixing sulphur and mercury in the ratio of 5:1 by weight in a stoneware vessel and stirring the mix till a black coloured powdery mass results; (b) mixing the black powdery mass with lime juice in the proportions of 500 cc. for every 60 gms. Of the said powdery mass to form a paste and transferring the same to an earthenware vessel; (c) the earthenware vessel is covered with another earthenware pot containing cold water and the entire assembly is placed on fire lit by burning wood selected from plum, tamarind or guava trees whereby the powdery mass sublimes and condenses below the vessel containing water; (d) repeating the steps of sublimation and condensation as in step (c) at least two to three times to achieve the desired degree of purity; (e) transferring the sublimate in a stone bowl and crushed before being transferred to an iron bowl followed by heating on a wood fire, the entire mass being stirred with an iron spoon; (f) continuing heating of the powdery mass under stirring till it is transformed into a liquid; (g) crafting a banana leaf in the shape of a bowl, surrounding the same with cowdung and pouring the liquid mass from step (f), followed by careful packing with banana leaf which in turn is completely covered with cowdung and the whole is allowed to stand for at least 12 hours wherefrom the liquid mass turns into solid; (h) crushing the said solid mass into powder, followed by mixing the mass with asafoetida (hing) and black "jeera” in proportions of 1:6 to 10:6 by weight with respect to the black powdery mass of step (a) till there is produced a uniform mass, and (i) forming the product from step (h) into orally administrable tablets of various strengths.
Full Text The present invention relates to a process for preparing an ayurvedic
medicament effective against Leukaemia and certain forms of carcinoma. More
particularly the subject invention pertains to a novel process for preparing an
ayurvedic medicament which acts effectively against myeloid leukaemia (both
chronic and acute), aplastic anaemia, plastic anaemia, lung cancer, cancer of
colon and other regions of intestine, cancer in different joints, brain tumor, but
excluding cancer in the throat and regions of the mouth including denture. The
products, namely, the ayurvedic medicaments, are also new, storage stable and
devoid of toxicity.
The conventional mode of treatment for carcinoma following detection
and determination by FNC, biopsy, needle biopsy or bone marrow examination
in case of leukaemia is usually carried out by adopting one or more of the
undernoted procedures-
(i) radiotherapy;
(ii) chemotherapy;
(iii) surgical intervention and
(iv) bone marrow transplantation.
It is to be noted that the mode of treatment depends on a number of factors
which are taken into account by the oncologist and/or the team of doctors
attending to the patient. Pathological and histopathological studies play an
important role in determining the stage or prognosis of the ailment. In case of
leukaemia, both chronic and myeloid, studies on Molecular Cytogenetics, Flow
Cytometry, Bone Marrow Aspiration and such other haemato-oncological
studies are adopted to determine the quantum of content (usually in
percentum) of Myeloid Series, Lymphoid Series, Erythroid Series,
Megacarvocytri Series, Plasma Cells, Morphology and presence of abnormal
cells/Blasts.
In case of cancer in different organs like lung, duodenum, prostrate,
breast, etc. in the early stages surgical intervention/removal appears to be the
preferred means of removing cancerous cells as completely as possible, which
often requires removal of lymph nodes for possible affliction with abnormal
tentacle-like cells growth, presence of which may result in secondary
metastasis.
Surgery is often followed by radiotherapy and/or chemotherapy, or vice-
versa.
Present day technological progress has provided two powerful tools in
carrying out investigative procedures, one is computer tomography (CT) scan
and the other being Magnetic Resonance Imaging (MRI). Those two are often
used to determine abnormalities in different regions of human system, often in
2

association with Ultrasonography (USG) and the conventional X-Ray imaging.
CT scan and MRI enable to determine exact location of affliction, which helps
the oncologist to adopt a proper regime of treatment.
All the foregoing modes of treatment of carcinoma suffer from different
drawbacks. For instance, radiotherapy no doubt destroys cancerous cells; but
they also destroy the healthy cells adjoining the afflicted area(s). Moreover,
overexposure to a-rays emanating from radioactive sources may cause
considerable harm. Hence, careful and judicious adjustment of dosage and
duration of exposure is very important for producing an effective and lasting
result. However, in recent times improved machines have been developed
which are capable of directing the radioactive rays to the affected part with
considerable degree of accuracy, causing virtually no harm to the adjoining
tissues. Unfortunately such improved facilities are only available at present in
metropolitan cities, and are considerably expensive. Vast majority of rural
population can ill afford to avail of benefits from such technological
advancements.
Chemotherapy is another treatment regime for different types of
carcinoma. Drugs are Adriamycin, Vancomycin, Vincristin, Zerodol and host
others have been used widely by oncologists for treating cancer. Another
medicament of rather recent origin isolated from vegetative sources is Taxol
Carboplatin. All the above-named products have pronounced toxicity and
produce side effects like nausea, vomiting, loss of appetite, loss of hair,
appearance of rash, etc. in the course of treatment. In some cases, bleeding
from nasal cavity has also been reported. The undesirable side effects and
toxicity often stand in the way of administration of such medicaments over a
prolonged period of time, apart from the cost consideration.
For combating leukaemia, the best possible course of action known till
date is bone marrow transplantation, which is done in hospitals and cancer
institutes in Canada, U.K., U.S.A. and such other advanced countries. This
necessitates extreme care and maintenance of germ-free surrounding, as in the
initial stages of bone-marrow replacement, immunity level takes a dip. It takes
a long time to regain the normal level of immunity. Till such time the patient
needs to be kept in a hermetically sealed sterile atmosphere devoid of any
contaminant. Such arrangements and facilities have not yet been attained in
India, thereby making it possible only for affluent section of people to avail of
this mode of treatment in U.S.A., Canada or U.K. Recently this procedure has
been initiated in a couple of advanced hospitals in Singapore, which promises
the recent trends in carrying out bone transplantation. Even in Singapore the
expenses for effecting bone marrow transplantation are quite considerable,
judging from Indian standards, and thus this mode of treatment is likely to
3

remain out of reach for multitude of Indians who have difficulty to eke out a
decent living.
The present invention aims at providing a novel medicament for treating
leukaemia and certain other forms of carcinoma which is prepared from
common inexpensive raw materials available indigenously.
The principal object of the invention is to provide a novel process for
preparing an ayurvedic medicament which is effective against leukaemia and
certain other forms of carcinoma.
A further object of this invention is to provide a process for making an
ayurvedic medicament which is made entirely from indigenously available raw
materials, by adopting simple procedures and avoiding use of sophisticated
machinery.
A still further object of this invention is to provide an ayurvedic
medicament effective against leukaemia and certain other forms of carcinoma
which is non-toxic, free from side effects and shows no contra-indications even
on prolonged administration.
Another object of this invention is to provide an ayurvedic medicament
effective against leukaemia and certain other forms of carcinoma which is not
only storage stable, but also can be made in orally administrable tablet or
capsule form, avoiding intravenous, intramuscular, peritoneal or subcutaneous
routes.
The foregoing objects are achieved by the present invention which
provides a process for preparing an ayurvedic medicament effective against
Leukaemia and certain forms of carcinoma which comprises-
(a) mixing sulphur and mercury in the ratio of 5:1 by weight in a stoneware
vessel and stirring the mix till a black coloured powdery mass results;
(b) mixing the black powdery mass with lime juice in the proportions of 500
cc. for every 60 gms. of the said powdery mass to form a paste and
transferring the same to an earthenware vessel;
(c) the earthenware vessel is covered with another earthenware pot
containing cold water and the entire assembly is placed on fire lit by
burning wood selected from plum, tamarind or guava trees whereby the
powdery mass sublimes and condenses below the vessel containing
water;
4

(d) repeating the steps of sublimation and condensation as in step(s) at
least two to three times to achieve the desired degree of purity;
(e) transferring the sublimate in a stone bowl and crushed before being
transferred to an iron bowl followed by heating on a wood fire, the
entire mass being stirred with an iron spoon;
(f) continuing heating of the powdery mass under stirring till it is
transformed into a liquid;
(g) crafting a banana leaf in the shape of a bowl, surrounding the same
with cowdung and pouring the liquid mass from step (f), followed by
careful packing with banana leaf which in turn is completely covered
with cowdung and the whole is allowed to stand for at least 12 hours
wherefrom the liquid mass turns into solid;
(h) crushing the said solid mass into powder, followed by mixing the mass
with asafoetida (hing) and black "Jeers" in proportions of 1:6 to 10:6 by
weight with respect to the black powdery mass of step (a) till there is
produced a uniform mass, and
(i) forming the product from step (h) into orally administrable tablets of
various strengths.
The initial reaction between Sulphur and mercury is conducted at a slightly
elevated temperature between 70°C and 80°C.
Heating of the earthenware pot over a wood fire to bring about a
sublimation of black sulphide of mercury is carried out at a temperature of
around 75°C - 80°C over a duration of around half an hour.
The purified mass of sulphide of mercury obtained after successive
sublimation and condensation is wetted and/or mixed with limejuice before
being heated in a clean iron bowl and stirred with an iron spoon, at a
temperature not exceeding 85°C, until the entire mass turns into a liquid. Lime
juice is added in an amount of 500 - 1000 ml, preferably 500 - 800 ml, for
every 60 - 70 gm of purified mass both for wetting and also for achieving
better activity of the end product.
The aforesaid liquid mass is poured into a bowl-shaped receptacle,
crafted from banana leaf, preferably of banana trees of "Kanthalf or "Kali
BabW variety (Musa sapieltum, Linn.), followed by careful packing with banana
leaf. The said receptacle with its contents are completely covered by fresh
5

cowdung and the whole is allowed to stand for at least 12 hours to permit the
liquid contents to be transformed into solid.
The solidified mass is then crushed in a porcelain / glass mortar and
pestle and formed into tablets or capsules. In preparing the tablets, use may be
made to tamarind starch to act as binder. For making capsules, empty shells are
carefully filled with the medicament and then sealed with an inert sealant as
available in the market.
The novel medicament of the present invention may be administered
through oral route and the dosage is determined by body weight of the patient
and also the stage up to which the ailment has proceeded. The product is
administrable from stage 1 and can be continued into stages 2 and 3.
In treating patients suffering from myeloid leukaemia, it is often found
that haemoglobin and platelet counts are irregular and not stabilized. An
increase in the blast cells count results in an attack of the bone marrow, which
weakens the patient and often shows a rise in the body temperature and
appearance of rash and/or eruption in different parts of the body. In certain
instances bleeding occurs from nose, gum and also from anal areas.
Administration of medicament of the present invention for a duration of
3 to 4 weeks shows distinct improvement and it is found that haemoglobin and
platelet counts become stable, with the decrease in blast cell. Patients' fever
subsides and bleeding stops within a week from the commencement of
treatment with the subject Ayurvedic medicament, and all round improvement
in the patients' condition is manifested within 3 months' time.
Dosage of the medicament is determined on the basis of the body
weight of the patient. Administration of medicament can be commenced from
stage 1 of the onset of carcinoma or leukaemia, as the case may be, and may
be continued further into the second and third stages.
The efficacy of the medicament is observed in all the three stages,
namely, 1st, 2nd and 3rd stages. Controlling of blood vessels or closure of their
rupture starts within one week from the commencement of administration of
medicament and as mentioned earlier, a pronounced improvement in the
general condition of the patient in observed within 3 months' time.
The invention will be further amplified by the following working example
which is given by way of illustration and not by way of limitation:
6

Example -1
50-60 gm of ordinary sulphur (of rhombic variety) is mixed with 10-12
gm of mercury in an approximate ratio of 5:1 (S:Hg) by weight in a stone or
porcelain bowl, preferably at an elevated temperature varying between 70°C
and 80°C. After sometime a black powdery mass results, which is mixed with
approximately Vz litre of fresh lime juice and the entire mass is transferred to a
mud pot.
A wood fire is lit and the mud pot with its contents is placed on wood
fire, which in turn is covered with another mud pot containing cold water. As
the lower pot gets heated to a temperature of 75°C - 80°C the mercuric
sulphide sublimes and collects at the bottom of the earthenware pot
containing water. Wood for burning is collected from plum, guava or tamarind
trees, the first-named being most preferred. Each cycle of operation is
conducted over a period of around 30 minutes.
The steps of sublimation and condensation are repeated, at least two to
three times, to attain desired degree of purity. The purified mass is then
carefully mixed with 500 - 750 c3 of fresh lime juice to form into a paste and
the whole is transferred to a stone bowl and stirred with an iron spoon while
being heated gradually over wood fire. Heating is continued taking care that
temperature does not exceed 85°C, till the entire mass turns into a liquid.
Meanwhile a banana leaf from trees of Kanthali or Kalibabu variety is
crafted into the shape of a bowl, which is surrounded by fresh cowdung, and
the liquid mass is carefully poured into the bowl-shaped receptacle. After
pouring the liquid, the bowl with its contents is entirely covered with fresh
cowdung and allowed to stand undisturbed for at least 12 hours, whereupon
the said liquid mass turns into solid.
The solidified mass is crushed into powder, to which is added 10 gm of
Hing (Asafoetida) and 100 gm of black jeera and crushing continued till
formation of a uniform mass.
The powdery mass is thereafter formed into tablets of varying strengths
for oral administration. Use may be made of powder of tamarind seed kernels
rich in starch which acts as a binder. Tablets thus produced are kept in sealed
glass or HDPC (high density polyethylene) or 'Teflon' (polytetrafluoroethylene)
container, the last named container being preferred. The product shows good
storage stability and retains its activity over a period of nearly one year.
7

The powdery product may also be filled inside empty capsules followed
by sealing. Be it tablets or capsules, no other chemical surfactants, stabilizers or
adjuvant are used.
In conducting treatment with the medicament prepared according to the
process of this invention certain diet restrictions are to be observed. Food items
such as fish, egg, mustard oil, molasses, pulses/lentils, sour fruits and
vegetables, and items responsible for increasing uric acid are to be completely
avoided.
Dosage for the medicament of this invention depends mainly on the
body weight and the stage up to which the disease has progressed. For stage 3
patients, frequency of administration also needs to be adjusted for providing
relief to the patient.
Example - 2
The product of this invention was administered orally to patients
suffering fro different types of carcinoma and the clinical data along with
observations are given below in tabular form. Patient Nos. 1, 2 and 3 were
pronounced as 'terminal cases' by the hospital authorities where they were
undergoing treatment. Patients identifies are not being disclosed as per their
request.

PATIENT & CONDITION PERIOD OF INITIAL FINAL OBSERVATION
MALADY ADMINIS-
TRATION VALUE VALUE
1-Male i. Pimples all From Hb-15.04 Hb-12.58 i. Pimples
Lung over body 18.06.07 cleared
Cancer to WBC- WBC-
ii. Large
tumour 20.11.07 reduced 76.00 ii. Weight
gain
FNAC on LDH - 600 LDH-
both sides 181.40 iii. Increase in
of the neck Platelet 1.5
lakhs Platelet 2.3 appetite
iii. Emanciated
and bed
ridden
iv. Total loss
of appetite lakhs iv. Can move
around
8

PATIENT &
MALADY CONDITION PERIOD
OF
ADMINIS-
TRATION INITIAL
VALUE FINAL
VALUE OBSERVATION
2-Male
BM Report
Apastic Anaemia
with dysery
thropaiesis
MC Report
Acute Leukaemia
Chemotherapy
undergone i. Eruptions
ii. Bleeding
iii. Chest
infection
iv. Loss of
bodyweight
v. Loss of
appetite From
21.01.05
to
13.07.07 Hb-4.1
WBC - 2300
Platelet
22-24000
Av. Hb-7.59
WBC - 8200
LDH-
181.40
Platelet 1.67
lakhs i. Eruptions
gone
ii. Bleeding
stopped
iii. Weight
gain
iv. Chest
infection
cleared
v. Increase in
appetite
3-Male
Peerless Hospital
Acute Myeloid
Leukaemia i. High
temperatur
e
ii. Hacking
cough
iii. Chest
infection
iv. Bleeding
v. Loss of
appetite
vi. Difficulty in
movement From
12.07.07
to
04.09.07 Hb-9.0
Blast Cell
34%
TC-39,500
WBC-
42,200
RBC - 2,800
Platelet -
65000-
70000 (Av.) Hb-9.34
Blast Cell
15%
TC - 36,500
WBC-
36,000
RBC-3210
Platelet 1.5
to 2.57 lakhs
(Av.) i. Normal
Temperat
ure
ii. No cough
iii. Chest
clear
iv. Bleeding
stopped
v. Appetite
improved
vi. Can move
around
4-Female
Stomach Cancer i. Acute pain
in stomach
ii. vomiting
iii. acidity-
burning
sensation
iv. constipation
v. Loss of
appetite From
03.06.07
to
28.10.07 Hb-12.3
WBC-3300
Platelet -
60000
ESR-50(1st
Hr.)
Bleeding
Time -1 m
45 sec.
Clotting time
3 m. Hb-9.9
WBC-7.00
RBC-3.1
mil.
Platelet -1.8
lakhs
Biochemistry
Report -
Normal i. Relief
from
Stomach
Pain
ii. Vomiting
stopped
iii. Acidity
checked
iv. No more
burning
sensation
v. Appetite
better
9

58 sec vi. Movement
of bowels
5-Male i. Difficulty in From Hb- Hb-15.3 i. Can
1. Cervical node swallowing 29.07.07 12.8gm% cu.mm. swallow
metastatic to Total Total
squamous cell ii. Neck node 30.11.07 Leucocytic Leucocytic ii. Weight
carcinoma swelling Couunt
8500/cu.mm. Couunt
9200Cu.mm. gain
II. iii. Reduced Differential Differential
Mucoepidermoid urinary Leucocytic Leucocytic
carcinoma of the frequency Count Count -
salivary gland Neutrophil
55%
Lymphocyte
38%
Monocyte
3%
Eosinophil
4%
Basophil 0% Normal
ESR-1sthr.
12 mm.
Platelet 3.14
lakhs
Creatinine
0.87 mg.
Urea
Nitrogen
10.00 mg./dl
Serum Urea
21.00
PP Sugar
120
Fasting
Sugar - 84
Neutrophil
70%
Lymphocyte
28%
Monocyte
1%
Eosinophil
1%
Basophil 0%
Bleeding
Time 1 min.
25 sec.
Coagulation
Time-
3 min. 40
sec.
From the foregoing it may be noted that despite variations in the type of
ailment, the product o this invention has been able to provide relief to the
patients suffering from carcinoma. For acute case like (2), 2 doses, each
comprising of 182 mg of medicament were administered, and would continue
to be administered for a period of 6 months, followed by 1 dose per week for 1
year. Thereafter a comprehensive test needs to be carried out to ascertain the
10

improvement, prevention of secondary metastasis and sustained or even total
absence of abnormal, cancerous cells.
While the invention has been described in detail and with reference to
specific embodiments thereof, it will be appeared to one skilled in the art that
various changes and modifications can be made therein without deviating or
departing from the spirit and scope of the invention. Thus the disclosure
contained herein includes within its ambit the obvious equivalents and
substitutes as well.
Having described the invention in detail with particular reference to the
illustrative examples given above, it will now be more particularly defined by
means of claims appended hereafter.
11

I claim :
1. A process for preparing an ayurvedic medicament effective against
Leukaemia and certain forms of carcinoma which comprises-
(a) mixing sulphur and mercury in the ratio of 5:1 by weight in a stoneware
vessel and stirring the mix till a black coloured powdery mass results;
(b) mixing the black powdery mass with lime juice in the proportions of 500
cc. for every 60 gms. Of the said powdery mass to form a paste and
transferring the same to an earthenware vessel;
(c) the earthenware vessel is covered with another earthenware pot
containing cold water and the entire assembly is placed on fire lit by
burning wood selected from plum, tamarind or guava trees whereby the
powdery mass sublimes and condenses below the vessel containing
water;
(d) repeating the steps of sublimation and condensation as in step (c) at
least two to three times to achieve the desired degree of purity;
(e) transferring the sublimate in a stone bowl and crushed before being
transferred to an iron bowl followed by heating on a wood fire, the
entire mass being stirred with an iron spoon;
(f) continuing heating of the powdery mass under stirring till it is
transformed into a liquid;
(g) crafting a banana leaf in the shape of a bowl, surrounding the same
with cowdung and pouring the liquid mass from step (f), followed by
careful packing with banana leaf which in turn is completely covered
with cowdung and the whole is allowed to stand for at least 12 hours
wherefrom the liquid mass turns into solid;
(h) crushing the said solid mass into powder, followed by mixing the mass
with asafoetida (hing) and black "Jeers" in proportions of 1:6 to 10:6 by
weight with respect to the black powdery mass of step (a) till there is
produced a uniform mass, and
(i) forming the product from step (h) into orally administrable tablets of
various strengths.

2. A process as claimed in Claim 1, wherein the initial reaction between
mercury and sulphur is carried out in a slightly elevated temperature
ranging between 70° and 80°C.
3. A process as claimed in Claim 1, wherein the heating in step (c) is carried
out at a temperature of between 75° and 80°C, produced by burning wood
from plum tree, for a duration of around 30 mins.
4. A process as claimed in Claims 1 to 3, wherein the purified mass obtained
in step (d) is wetted and/or mixed with lime juice in an amount of 500 to
1000 ml, preferably 500 to 800 ml, for every 60 - 70 gm of the said mass,
before being subjected to heating in an iron bowl for achieving better
activity of the end product.
5. A process as claimed in Claim 1, wherein heating of the powdery mass is
conducted in step (f) at a temperature not exceeding 85°C.
6. A process as claimed in Claim 1, wherein the banana leaves are preferably
collected from banana trees of "Kanthali" or "KalibabW variety {Musa
sapieltum Linn.).
7. A process as claimed in Claim 1, wherein tamarind starch is employed as
a binder in preparing the final product into tablet form.

8. A process for preparing an ayurvedic medicament effective against
leukaemia and certain other carcinoma, substantially as hereinbefore
described with particular reference to the illustrative Examples.
9. An ayurvedic medicament effective against leukaemia and certain other
forms of carcinoma formulated from sulphur and mercury, mixed with lime
juice and further including asafoetida (hing) and black jeera in proportion as
enumerated in claims 1 and 4, and made into orally administrable tablet
form.
10. An ayurvedic medicament effective against leukaemia and certain other
forms of carcinoma, substantially as hereinbefore described.
Dated this 27th day of December 2007

13

Conventional treatment for different forms of carcinoma has been quite
expensive and often shows undesirable side effects.
The present invention attempts to mitigate the sufferings of patients
suffering from carcinoma and provides a process for preparing an
ayurvedic medicament effective against Leukaemia and certain forms of
carcinoma which comprises-
(a) mixing sulphur and mercury in the ratio of 5:1 by weight in a
stoneware vessel and stirring the mix till a black coloured powdery
mass results;
(b) mixing the black powdery mass with lime juice in the proportions
of 500 cc. for every 60 gms. Of the said powdery mass to form a
paste and transferring the same to an earthenware vessel;
(c) the earthenware vessel is covered with another earthenware pot
containing cold water and the entire assembly is placed on fire lit
by burning wood selected from plum, tamarind or guava trees
whereby the powdery mass sublimes and condenses below the
vessel containing water;
(d) repeating the steps of sublimation and condensation as in step (c) at
least two to three times to achieve the desired degree of purity;
(e) transferring the sublimate in a stone bowl and crushed before
being transferred to an iron bowl followed by heating on a wood
fire, the entire mass being stirred with an iron spoon;
(f) continuing heating of the powdery mass under stirring till it is
transformed into a liquid;

(g) crafting a banana leaf in the shape of a bowl, surrounding the same
with cowdung and pouring the liquid mass from step (f), followed
by careful packing with banana leaf which in turn is completely
covered with cowdung and the whole is allowed to stand for at least
12 hours wherefrom the liquid mass turns into solid;
(h) crushing the said solid mass into powder, followed by mixing the
mass with asafoetida (hing) and black "jeera” in proportions of 1:6 to
10:6 by weight with respect to the black powdery mass of step (a)
till there is produced a uniform mass, and
(i) forming the product from step (h) into orally administrable tablets
of various strengths.

Documents:

01734-kol-2007-abstract.pdf

01734-kol-2007-claims.pdf

01734-kol-2007-correspondence others.pdf

01734-kol-2007-description complete.pdf

01734-kol-2007-form 1.pdf

01734-kol-2007-form 2.pdf

01734-kol-2007-form 3.pdf

01734-kol-2007-form 9.pdf

01734-kol-2007-pa.pdf

1734-KOL-2007-ABSTRACT-1.1.pdf

1734-KOL-2007-AMENDED PAGES.pdf

1734-KOL-2007-CANCELLED PAGES.pdf

1734-KOL-2007-CLAIMS-1.1.pdf

1734-kol-2007-correspondence 1.1.pdf

1734-kol-2007-correspondence 1.3.pdf

1734-kol-2007-correspondence 1.4.pdf

1734-kol-2007-correspondence 1.5.pdf

1734-KOL-2007-CORRESPONDENCE-1.1.pdf

1734-KOL-2007-CORRESPONDENCE.1.2.pdf

1734-KOL-2007-CORRESPONDENCE.pdf

1734-kol-2007-correspondence1.6.pdf

1734-KOL-2007-DESCRIPTION (COMPLETED)-1.1.pdf

1734-kol-2007-examination report.pdf

1734-KOL-2007-FORM 1-1.1.pdf

1734-kol-2007-form 18.pdf

1734-KOL-2007-FORM 2-1.1.pdf

1734-kol-2007-form 3.pdf

1734-kol-2007-form 9.pdf

1734-KOL-2007-FORM-27.pdf

1734-kol-2007-granted-abstract.pdf

1734-kol-2007-granted-claims.pdf

1734-kol-2007-granted-description (complete).pdf

1734-kol-2007-granted-form 1.pdf

1734-kol-2007-granted-form 2.pdf

1734-kol-2007-granted-specification.pdf

1734-kol-2007-others 1.1.pdf

1734-KOL-2007-OTHERS.pdf

1734-kol-2007-pa.pdf

1734-KOL-2007-REPLY TO EXAMINATION REPORT.pdf

1734-kol-2007-reply to examination report1.1.pdf


Patent Number 248741
Indian Patent Application Number 1734/KOL/2007
PG Journal Number 33/2011
Publication Date 19-Aug-2011
Grant Date 17-Aug-2011
Date of Filing 27-Dec-2007
Name of Patentee MAITY PRASANTA
Applicant Address P.O. & VILLAGE: KAMDEVPUR, DIST. 24-PARGANAS (N)
Inventors:
# Inventor's Name Inventor's Address
1 MAITY PRASANTA P.O. & VILLAGE: KAMDEVPUR, DIST. 24-PARGANAS (N), PIN: 700 125
PCT International Classification Number A61K 33/28
PCT International Application Number N/A
PCT International Filing date
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 NA